A novel information retrieval model for high-throughput molecular medicine modalities

Cancer Informatics

Volumn 8, Issue , 2009, Pages 1-17

  Wehbe, Firas H ^a   Brown, Steven H ^a,b   Massion, Pierre P ^c   Gadd, Cynthia S ^a   Masys, Daniel R ^a   Aliferis, Constantin F ^a,d,e  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b US Department of Veteran Affairs   (United States)

^c VANDERBILT UNIVERSITY   (United States)

^d NEW YORK UNIVERSITY   (United States)

^e NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Clinical bioinformatics; Information retrieval; Molecular medicine; Predictive computational models; Semantic model

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; VINCRISTINE;

ALGORITHM; B CELL LYMPHOMA; BIOINFORMATICS; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER SURVIVAL; GENE EXPRESSION; GENETIC VARIABILITY; HUMAN; LARGE CELL LYMPHOMA; LYMPH NODE METASTASIS; MICROARRAY ANALYSIS; PHENOTYPE; PROGNOSIS; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 77649254585     PISSN: 11769351     EISSN: 11769351     Source Type: Journal    
DOI: 10.4137/cin.s964     Document Type: Review

References (60)

1. Aitken, J.S., Webber, B.L. and Bard, J.B. 2004. Part-of relations in anatomy ontologies: a proposal for RDFS and OWL formalisations. Pac. Symp. Biocomput., 166-77.
2. Alizadeh, A.A., Eisen, M.B., Davis, R.E. et al. 2000. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature, 403(6769):503-11.
3. Altman, R.B., Flockhart, D.A., Sherry, S.T. et al. 2003. Indexing pharmacogenetic knowledge on the World Wide Web. Pharmacogenetics, 13(1):3-5.
4. Ando, Y., Saka, H., Ando, M. et al. 2000. Polymorphisms of UDP-glucuronosyltransferase gene and irinotecan toxicity: a pharmacogenetic analysis. Cancer Res., 60(24):6921-6.
5. Aphinyanaphongs, Y., Tsamardinos, I., Statnikov, A. et al. 2005. Text Categorization Models for High-Quality Article Retrieval in Internal Medicine. Journal of the American Medical Informatics Association, 12(2):207-16.
6. Ashburner, M., Ball, C.A., Blake, J.A. et al. 2000. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet., 25(1):25-9.
7. Baader, F. 2003. The description logic handbook theory, implementation, and applications Cambridge University Press, Cambridge, UK.
8. Ball, C.A., Brazma, A., Causton, H. et al. 2004. Submission of microarray data to public repositories. PLoS. Biol., 2(9):E317.
9. Barrett, T., Troup, D.B., Wilhite, S.E. et al. 2007. NCBI GEO: mining tens of millions of expression profiles - database and tools update. Nucleic Acids Res., 35 Database issue:D760-D65.
10. Bell, D.W., Lynch, T.J., Haserlat, S.M. et al. 2005. Epidermal growth factor receptor mutations and gene amplification in non-small-cell lung cancer: molecular analysis of the IDEAL/INTACT gefitinib trials. J. Clin. Oncol., 23(31):8081-92.
11. Brazma, A., Hingamp, P., Quackenbush, J. et al. 2001. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat. Genet., 29(4):365-71.
12. Broad Institute - Datasets - http://www.broad.mit.edu/tools/data.html - Last Update: 2005.
13. Broad Institute - Software - http://www.broad.mit.edu/tools/software.html - Last Update: 2008.
14. Burgun, A. 2006. Desiderata for domain reference ontologies in biomedicine. J. Biomed. Inform., 39(3):307-13.
15. Buyse, M., Loi, S., van't Veer, L. et al. 2006. Validation and Clinical Utility of a 70-Gene Prognostic Signature for Women With Node-Negative Breast Cancer. jnci., 98(17):1183-92.
16. Ciotti, M., Chen, F., Rubaltelli, F.F. et al. 1998. Coding defect and a TATA box mutation at the bilirubin UDP-glucuronosyltransferase gene cause Crigler-Najjar type I disease. Biochim. Biophys. Acta., 1407(1):40-50.
17. Couzin, J. 2007. Diagnostics. Amid debate, gene-based cancer test approved. Science, 315(5814):924.
18. Discovery Systems Laboratory - Omics Retrieval Ontology - http://www.dsl-lab.org/supplements/omicsontology/ - Last Update: 2008.
19. Edgar, R., Domrachev, M. and Lash, A.E. 2002. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res., 30(1):207-10.
20. Erban, J.K. and Lau, J. 2006. On the Toxicity of Chemotherapy for Breast Cancer-the Need for Vigilance. J. Natl. Cancer Inst., 98(16):1096-7.
21. Food and Drug Administration - Table of Valid Genomic Biomarkers in the Context of Approved Drug Labels - http://www.fda.gov/cder/genomics/genomic- biomarkers-table.htm-Last Update: 4-7-2008.
22. Glas, A.M., Floore, A., Delahaye, LJMJ. et al. 2006. Converting a breast cancer microarray signature into a high-throughput diagnostic test. BMC Genomics, 7:278.
23. Golub, T.R., Slonim, D.K., Tamayo, P. et al. 1999. Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring. Science, 286(5439):531-7.
24. Hassett, M.J., O'Malley, A.J., Pakes, J.R. et al. 2006. Frequency and Cost of Chemotherapy-Related Serious Adverse Effects in a Population Sample of Women With Breast Cancer. jnci., 98(16):1108-17.
25. Hoffman, M., Arnoldi, C. and Chuang, I. 2005. The clinical bioinformatics ontology: a curated semantic network utilizing RefSeq information. Pac. Symp. Biocomput., 139-50.
26. Innocenti, F., Undevia, S.D., Iyer, L. et al. 2004. Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan. J. Clin. Oncol., 22(8):1382-8.
27. Jones, A., Hunt, E., Wastling, J.M. et al. 2004. An object model and database for functional genomics. Bioinformatics, 20(10):1583-90.
28. Jones, A.R., Pizarro, A., Spellman, P. et al. 2006. FuGE: Functional Genomics Experiment Object Model. OMICS, 10(2):179-84.
29. Knublauch, H., Musen, M.A. and Rector, A.L. 2004. Editing description logic ontologies with the protege-owl plugin. International Workshop on Description Logics.,
30. Li, L. 2006. Survival prediction of diffuse large-B.-cell lymphoma based on both clinical and gene expression information. Bioinformatics, 22(4):466-71.
31. Lynch, T.J., Bell, D.W., Sordella, R. et al. 2004. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N. Engl. J. Med., 350(21):2129-39.
32. Manduchi, E., Grant, G.R., He, H. et al. 2004. RAD and the RAD Study-Annotator: an approach to collection, organization and exchange of all relevant information for high-throughput gene expression studies. Bioinformatics, 20(4):452-9.
33. Marsh, S. and McLeod, H.L. 2006. Pharmacogenomics: from bedside to clinical practice. Hum. Mol. Genet., 15(1):R.89-R.93.
34. Mathew, J.P., Taylor, B.S., Bader, G.D. et al. 2007. From Bytes to Bedside: Data Integration and Computational Biology for Translational Cancer Research. PLoS Computational Biology, 3(2):e12.
35. McGuinness, D.L. and van Harmelen, F. 2004. OWL Web Ontology Language Overview. W3C Recommendation, 10:2004-03.
36. National Cancer Institute - REMBRANDT Home page - http://rembrandt.nci. nih.gov - Last Update: 2005.
37. Ntzani, E.E. and Ioannidis, J.P. 2003. Predictive ability of DNA microarrays for cancer outcomes and correlates: an empirical assessment. Lancet, 362(9394):1439-44.
38. Oliver, D.E., Rubin, D.L., Stuart, J.M. et al. 2002. Ontology development for a pharmacogenetics knowledge base. Pac. Symp. Biocomput., 65-76.
39. onso-Calvo, R., Maojo, V., Billhardt, H. et al. 2007. An agent- and ontology-based system for integrating public gene, protein, and disease databases. J. Biomed. Inform., 40(1):17-29.
40. Pepe, M.S., Etzioni, R., Feng, Z. et al. 2001. Phases of biomarker development for early detection of cancer. J. Natl. Cancer Inst., 93(14):1054-61.
41. Perez-Rey, D., Maojo, V., Garcia-Remesal, M. et al. 2006. ONTOFUSION: ontology-based integration of genomic and clinical databases. Comput. Biol. Med., 36(7-8):712-30.
42. Quackenbush, J. 2006. Microarray analysis and tumor classification. N. Engl. J. Med., 354(23):2463-72.
43. Rhodes, D.R., Kalyana-Sundaram, S., Mahavisno, V. et al. 2007. Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia, 9(2):166-80.
44. Rhodes, D.R., Yu, J., Shanker, K. et al. 2004. ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia, 6(1):1-6.
45. Rosenwald, A., Wright, G., Chan, W.C. et al. 2002. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N. Engl. J. Med., 346(25):1937-47.
46. Ross, J.S. and Ginsburg, G.S. 2003. The integration of molecular diagnostics with therapeutics. Implications for drug development and pathology practice. Am. J. Clin. Pathol., 119(1):26-36.
47. Ross, J.S., Schenkein, D.P., Kashala, O. et al. 2004. Pharmacogenomics. Adv. Anat. Pathol., 11(4):211-20.
48. Shipp, M.A., Ross, K.N., Tamayo, P. et al. 2002. Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat. Med., 8(1):68-74.
49. Simon, R. 2005. Roadmap for developing and validating therapeutically relevant genomic classifiers. J. Clin. Oncol., 23(29):7332-41.
50. Simon, R. and Zhao, Y. BRB.-ArrayTools Data Archive for Human Cancer Gene Expression: A Unique and Efficient Data Sharing Resource. Cancer Informatics 6, 9-15. 4-21-2008. Ref Type: Journal (Full).
51. Sioutos, N., de, C.S., Haber, M.W. et al. 2007. NCI Thesaurus: a semantic model integrating cancer-related clinical and molecular information. J. Biomed. Inform., 40(1):30-43.
52. Smith, B., Ceusters, W., Klagges, B. et al. 2005. Relations in biomedical ontologies. Genome Biol., 6(5):R.46.
53. Sobie, E.A., Guatimosim, S., Song, L.S. et al. 2003. The challenge of molecular medicine: complexity versus Occam's razor. J. Clin. Invest., 111(6):801-3.
54. The International Non-Hodgkin's Lymphoma Prognostic Factors Project 1993, "A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project." N. Engl. J. Med., 329(14):987-94.
55. van de Vijver, M.J., He, Y.D., van't Veer, L.J. et al. 2002. A Gene-Expression Signature as a Predictor of Survival in Breast Cancer. New England Journal of Medicine, 347(25):1999.
56. van't Veer, L.J., Dai, H., van de Vijver, M.J. et al. 2002. Gene expression profiling predicts clinical outcome of breast cancer. Nature, 415(6871):530-6.
57. Vose, J.M. 1998. Current approaches to the management of non-Hodgkin's lymphoma. Semin. Oncol., 25(4):483-91.
58. Weigelt, B., Hu, Z., He, X. et al. 2005. Molecular Portraits and 70-Gene Prognosis Signature Are Preserved throughout the Metastatic Process of Breast Cancer. Cancer Research, 65(20):9155-8.
59. Wilczynski, N., Morgan, D., Haynes, R.B. et al. 2005. An overview of the design and methods for retrieving high-quality studies for clinical care. BMC Medical Informatics and Decision Making, 5(1):20.
60. Wright, G., Tan, B., Rosenwald, A. et al. 2003. A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B-cell lymphoma. Proc. Natl. Acad. Sci. U.S.A, 100(17):9991-6.